← Leaderboards
Nicaise Ndembi
University Of Maryland Baltimore
$1,460,236
Attributed
$2,920,471
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $715.2K · FY2020–25$1M$750K$500K$250K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,920,471 · 1
By mechanism
R01$2,920,471 · 1
Top collaborators
- Manhattan E Charurat4 shared
- Miguel E Quinones-Mateu1 shared
Most similar at University Of Maryland Baltimore
Same institution · by research overlap
- William Albert Blattner$260,131,047
- Temidayo Olusade Ogundiran$2,514,281
- Manhattan E Charurat$19,344,390
- Alonso Heredia$3,865,060
- Yuxing Li$12,368,734
Others in their field
Other Emerging Leaders on “Fitness”
- Klaus Romero · Critical Path Institute$90,404,592
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$45,976,855
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$39,889,328
- Chris Karlovich · Leidos Biomedical Research, Inc.$38,534,220
- Russell T Hepple · California Pacific Med Ctr Res Institute$12,760,565
- John Damon Chodera · Sloan-Kettering Inst Can Research$11,593,483
Research focus
FitnessFutureAdherenceFailureAfricaArchivesAreaAnti-Retroviral AgentsAffectEvolutionCase ControlCellsClinically SignificantCloningCodeCohortCoupledDesignDrug ResistanceDrug Resistance PathwayCameroonEnv GenesEpidemiologyGag Gene
Grant awards (5)
Impact of Non - B HIV - 1 Subtype on second line Protease Inhibitor Regimens in Africa (INSPIRE)$688,829
R01 · FY2025 · AI · contact PI
Impact of Non - B HIV - 1 Subtype on second line Protease Inhibitor Regimens in Africa (INSPIRE)$313,674
R01 · FY2024 · AI · contact PI
Impact of Non - B HIV - 1 Subtype on second line Protease Inhibitor Regimens in Africa (INSPIRE)$621,170
R01 · FY2023 · AI · contact PI
Impact of Non - B HIV - 1 Subtype on second line Protease Inhibitor Regimens in Africa (INSPIRE)$715,198
R01 · FY2022 · AI · contact PI
Impact of Non - B HIV - 1 Subtype on second line Protease Inhibitor Regimens in Africa (INSPIRE)$581,600
R01 · FY2020 · AI · contact PI